SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3t6p'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CMA_A_SAMA105_0
(PROTEIN (MET
REPRESSOR))
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
4 / 8 GLU A 560
ARG A 563
ARG A 564
GLU A 551
None
0.87A 1cmaA-3t6pA:
undetectable
1cmaB-3t6pA:
1.3
1cmaA-3t6pA:
14.58
1cmaB-3t6pA:
14.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CMA_B_SAMB105_0
(PROTEIN (MET
REPRESSOR))
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
5 / 11 GLU A 560
ARG A 563
ARG A 564
LEU A 556
GLU A 551
None
1.02A 1cmaA-3t6pA:
undetectable
1cmaB-3t6pA:
1.3
1cmaA-3t6pA:
14.58
1cmaB-3t6pA:
14.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CMC_B_SAMB105_0
(MET REPRESSOR)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
5 / 10 GLU A 560
ARG A 563
ARG A 564
LEU A 556
GLU A 551
None
1.04A 1cmcA-3t6pA:
undetectable
1cmcB-3t6pA:
undetectable
1cmcA-3t6pA:
14.58
1cmcB-3t6pA:
14.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJ2_A_SAMA2200_0
(PROTEIN (METHIONINE
REPRESSOR))
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
5 / 12 GLU A 560
ARG A 563
ARG A 564
LEU A 556
GLU A 551
None
1.00A 1mj2A-3t6pA:
undetectable
1mj2B-3t6pA:
undetectable
1mj2A-3t6pA:
14.58
1mj2B-3t6pA:
14.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJ2_A_SAMA2201_0
(PROTEIN (METHIONINE
REPRESSOR))
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
5 / 9 GLU A 560
ARG A 563
ARG A 564
LEU A 556
GLU A 551
None
1.01A 1mj2A-3t6pA:
undetectable
1mj2A-3t6pA:
14.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJ2_C_SAMC1200_0
(PROTEIN (METHIONINE
REPRESSOR))
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
5 / 9 GLU A 560
ARG A 563
ARG A 564
LEU A 556
GLU A 551
None
1.02A 1mj2C-3t6pA:
undetectable
1mj2C-3t6pA:
14.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJ2_C_SAMC2199_0
(PROTEIN (METHIONINE
REPRESSOR))
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
5 / 12 GLU A 560
ARG A 563
ARG A 564
LEU A 556
GLU A 551
None
0.99A 1mj2C-3t6pA:
undetectable
1mj2D-3t6pA:
undetectable
1mj2C-3t6pA:
14.58
1mj2D-3t6pA:
14.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJL_A_SAMA200_0
(METHIONINE REPRESSOR
PROTEIN METJ)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
5 / 11 GLU A 560
ARG A 563
ARG A 564
LEU A 556
GLU A 551
None
1.03A 1mjlA-3t6pA:
undetectable
1mjlB-3t6pA:
1.4
1mjlA-3t6pA:
14.58
1mjlB-3t6pA:
14.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJO_A_SAMA199_0
(METHIONINE REPRESSOR)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
5 / 9 GLU A 560
ARG A 563
ARG A 564
LEU A 556
GLU A 551
None
0.99A 1mjoA-3t6pA:
undetectable
1mjoA-3t6pA:
14.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJO_B_SAMB200_1
(METHIONINE REPRESSOR)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
5 / 9 GLU A 560
ARG A 563
ARG A 564
LEU A 556
GLU A 551
None
0.96A 1mjoB-3t6pA:
undetectable
1mjoB-3t6pA:
14.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJO_C_SAMC200_0
(METHIONINE REPRESSOR)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
5 / 12 GLU A 560
ARG A 563
ARG A 564
LEU A 556
GLU A 551
None
0.98A 1mjoC-3t6pA:
undetectable
1mjoD-3t6pA:
undetectable
1mjoC-3t6pA:
14.58
1mjoD-3t6pA:
14.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJO_D_SAMD200_0
(METHIONINE REPRESSOR)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
5 / 9 GLU A 560
ARG A 563
ARG A 564
LEU A 556
GLU A 551
None
0.99A 1mjoC-3t6pA:
undetectable
1mjoC-3t6pA:
14.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1TCO_C_FK5C509_2
(FK506-BINDING
PROTEIN)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
5 / 11 ASP A 511
ARG A 569
VAL A 475
ILE A 478
ILE A 461
None
1.26A 1tcoC-3t6pA:
undetectable
1tcoC-3t6pA:
18.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2I30_A_SALA1200_1
(SERUM ALBUMIN)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
4 / 4 LEU A 539
ILE A 510
ILE A 513
ALA A 521
None
0.78A 2i30A-3t6pA:
2.7
2i30A-3t6pA:
20.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EL0_A_1UNA201_2
(PROTEASE)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
5 / 9 VAL A 590
ILE A 604
GLY A 607
ILE A 608
ALA A 596
None
0.89A 3el0B-3t6pA:
undetectable
3el0B-3t6pA:
12.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ELZ_B_CHDB200_0
(ILEAL BILE
ACID-BINDING PROTEIN)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
4 / 5 PRO A 280
VAL A 283
THR A 612
GLY A 611
None
1.16A 3elzB-3t6pA:
undetectable
3elzB-3t6pA:
17.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UQA_A_FK5A114_1
(UBIQUITIN-LIKE
PROTEIN SMT3,
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
5 / 10 ASP A 511
ARG A 569
VAL A 475
ILE A 478
ILE A 461
None
1.20A 3uqaA-3t6pA:
undetectable
3uqaA-3t6pA:
19.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZS3_A_ACTA1224_0
(THAUMATIN-LIKE
PROTEIN)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
4 / 5 SER A 415
GLU A 317
THR A 419
ASP A 320
None
1.39A 3zs3A-3t6pA:
undetectable
3zs3A-3t6pA:
20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K38_B_SAMB504_0
(ANAEROBIC
SULFATASE-MATURATING
ENZYME)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
5 / 12 CYH A 306
PHE A 295
GLU A 334
ARG A 614
LEU A 313
ZN  A1002 (-2.2A)
None
None
None
None
1.42A 4k38B-3t6pA:
undetectable
4k38B-3t6pA:
22.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5B8I_C_FK5C201_3
(PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
5 / 12 ASP A 511
ARG A 569
VAL A 475
ILE A 478
ILE A 461
None
1.18A 5b8iC-3t6pA:
undetectable
5b8iC-3t6pA:
17.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HBS_A_RTLA201_1
(RETINOL-BINDING
PROTEIN 1)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
4 / 8 LEU A 313
LYS A 416
THR A 420
TYR A 352
None
1.16A 5hbsA-3t6pA:
undetectable
5hbsA-3t6pA:
16.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HW8_D_FK5D201_1
(FK506-BINDING
PROTEIN 1)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
5 / 11 ASP A 511
ARG A 569
VAL A 475
ILE A 478
ILE A 461
None
1.10A 5hw8D-3t6pA:
undetectable
5hw8D-3t6pA:
18.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IMS_A_ACTA708_0
(ACETOLACTATE
SYNTHASE CATALYTIC
SUBUNIT,
MITOCHONDRIAL)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
3 / 3 GLY A 312
GLY A 311
GLN A 593
None
0.44A 5imsA-3t6pA:
undetectable
5imsA-3t6pA:
19.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HIS_A_TKTA508_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 3A)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
4 / 8 ILE A 510
ARG A 465
ARG A 569
TYR A 547
None
1.04A 6hisA-3t6pA:
undetectable
6hisB-3t6pA:
undetectable
6hisA-3t6pA:
13.20
6hisB-3t6pA:
13.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HIS_B_TKTB508_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 3A)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
4 / 8 ILE A 510
ARG A 465
ARG A 569
TYR A 547
None
1.03A 6hisB-3t6pA:
undetectable
6hisC-3t6pA:
undetectable
6hisB-3t6pA:
13.20
6hisC-3t6pA:
13.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HIS_C_TKTC508_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 3A)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
4 / 8 ILE A 510
ARG A 465
ARG A 569
TYR A 547
None
1.03A 6hisC-3t6pA:
undetectable
6hisD-3t6pA:
undetectable
6hisC-3t6pA:
13.20
6hisD-3t6pA:
13.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HIS_D_TKTD501_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 3A)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
4 / 8 ILE A 510
ARG A 465
ARG A 569
TYR A 547
None
1.03A 6hisD-3t6pA:
undetectable
6hisE-3t6pA:
undetectable
6hisD-3t6pA:
13.20
6hisE-3t6pA:
13.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HIS_E_TKTE501_0
(5-HYDROXYTRYPTAMINE
RECEPTOR 3A)
3t6p BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 2

(Homo
sapiens)
4 / 8 TYR A 547
ILE A 510
ARG A 465
ARG A 569
None
1.03A 6hisA-3t6pA:
undetectable
6hisE-3t6pA:
undetectable
6hisA-3t6pA:
13.20
6hisE-3t6pA:
13.20